All news

CVS Health settles DOJ opioid case for USD 315 million

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

CVS Health settled a USD 315 million case with the U.S. Department of Justice over allegations of unlawful opioid prescriptions, agreeing to enhanced monitoring and reporting. The company kept its fiscal 2026 adjusted EPS guidance and posted 7.30 percent year-over-year revenue growth in the second quarter. It declared a USD 0.665 quarterly dividend.

Read original source

CVS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.